吡柔比星
基本信息
产品名称：
吡柔比星
英文名称：
Pirarubicin
国产/进口：
进口
产地/品牌：
美国/TargetMol
型号：
参考报价：
面议
销售商：
总点击数：
66
更新日期：
2025-07-08
产品类别：
性能参数
Product Introduction
Bioactivity
英文名: Pirarubicin
描述: Pirarubicin (Theprubicin) 是一种蒽环类抗生素，是拓扑异构酶 II 抑制剂，可用于各种癌症的研究。
体外活性: Pirarubicin is rapidly taken up by M5076 cells and the intracellular concentration of pirarubicin reaches more than 2.5-fold that of doxorubicin. Pirarubicin is more effective than doxorubicin in terms of the 50% cell growth-inhibitory concentration in vitro. [1] Pirarubicin causes G0/G1 cell cycle arrest in MG-63 cells. Pirarubicin suppresses the expression of PCNA, cyclin D1, cyclin E and Bcl-2, and increases Bax expression in MG-63 cells. [2] Pirarubicin markedly relaxes contractions induced by noradrenaline (0.1 μM) in the aorta with endothelium, but not in that without endothelium. Pirarubicin-induced relaxation is inhibited by methylene blue (5 μM), hydroquinone (100 μM), phenidone (50 μM), haemoglobin (1 μM) and p-bromophenacyl bromide (50 μM), but not by indomethacin (25 μM). [3] Pirarubicin is approximately 2-5 times more potent than Adriamycin in SKUT1B, HEC1A, and BG1 cell lines. Pirarubicin also displays a reverse dose-response pattern of G2 block so that at high dose, cell cycle kinetics would mirror those of untreated controls. [4]
体内活性: Pirarubicin在携带M5076实体瘤的小鼠中，将肿瘤重量降低到对照组的60%，而Doxorubicin却没有效果。[1] 通过肝内动脉(h.i.a.)注射，Pirarubicin和Epirubicin对V x 2肿瘤有效，Pirarubicin的活性强于Epirubicin。[5]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: Ethanol : < 1 mg/mL (insoluble or slightly soluble)
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 7 mg/mL (11.15 mM)
关键字: Topoisomerase | Bacterial | inhibit | Pirarubicin | Autophagy | Inhibitor | Antibiotic
相关产品: Levofloxacin hydrate | Lupalbigenin | 9-amino-CPT | Topoisomerase II inhibitor 13 | Pazufloxacin Mesylate | Betulinic acid | Ac-Exatecan | Doxorubicin hydrochloride | Oxaquin TEA | Razoxane
相关库: Anti-Aging Compound Library | Drug Repurposing Compound Library | Approved Drug Library | Anti-Breast Cancer Compound Library | Anti-Cancer Drug Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library | Target-Focused Phenotypic Screening Library
Bioactivity
英文名: Pirarubicin
描述: Pirarubicin (Theprubicin) 是一种蒽环类抗生素，是拓扑异构酶 II 抑制剂，可用于各种癌症的研究。
体外活性: Pirarubicin is rapidly taken up by M5076 cells and the intracellular concentration of pirarubicin reaches more than 2.5-fold that of doxorubicin. Pirarubicin is more effective than doxorubicin in terms of the 50% cell growth-inhibitory concentration in vitro. [1] Pirarubicin causes G0/G1 cell cycle arrest in MG-63 cells. Pirarubicin suppresses the expression of PCNA, cyclin D1, cyclin E and Bcl-2, and increases Bax expression in MG-63 cells. [2] Pirarubicin markedly relaxes contractions induced by noradrenaline (0.1 μM) in the aorta with endothelium, but not in that without endothelium. Pirarubicin-induced relaxation is inhibited by methylene blue (5 μM), hydroquinone (100 μM), phenidone (50 μM), haemoglobin (1 μM) and p-bromophenacyl bromide (50 μM), but not by indomethacin (25 μM). [3] Pirarubicin is approximately 2-5 times more potent than Adriamycin in SKUT1B, HEC1A, and BG1 cell lines. Pirarubicin also displays a reverse dose-response pattern of G2 block so that at high dose, cell cycle kinetics would mirror those of untreated controls. [4]
体内活性: Pirarubicin在携带M5076实体瘤的小鼠中，将肿瘤重量降低到对照组的60%，而Doxorubicin却没有效果。[1] 通过肝内动脉(h.i.a.)注射，Pirarubicin和Epirubicin对V x 2肿瘤有效，Pirarubicin的活性强于Epirubicin。[5]
存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: Ethanol : < 1 mg/mL (insoluble or slightly soluble)
H2O : < 1 mg/mL (insoluble or slightly soluble)
DMSO : 7 mg/mL (11.15 mM)
关键字: Topoisomerase | Bacterial | inhibit | Pirarubicin | Autophagy | Inhibitor | Antibiotic
相关产品: Levofloxacin hydrate | Lupalbigenin | 9-amino-CPT | Topoisomerase II inhibitor 13 | Pazufloxacin Mesylate | Betulinic acid | Ac-Exatecan | Doxorubicin hydrochloride | Oxaquin TEA | Razoxane
相关库: Anti-Aging Compound Library | Drug Repurposing Compound Library | Approved Drug Library | Anti-Breast Cancer Compound Library | Anti-Cancer Drug Library | Inhibitor Library | Anti-Cancer Clinical Compound Library | Anti-Cancer Approved Drug Library | Anti-Cancer Active Compound Library | Target-Focused Phenotypic Screening Library
公司简介
TargetMol（陶术）作为一家全球性的生物医药领域高科技企业，我们致力于为高校、研究所、医院、企业等各类生物医药研发机构提供优质的产品和服务，为全球医药科学家更高效地完成科研工作助力。可提供20,000+种 抑制剂和激动剂 、800+种 化合物库 、19,000+种 天然产物 ，以及9,000+种 重组蛋白 、多种 多肽 、抗体 和 生命科学试剂盒 等。此外，在上海，TargetMol研发中心配备了 CADD & AIDD研究中心、药理实验室和药物化学合成 平台三大技术中心，可提供虚拟筛选、化合物活性测试、分子间结合力检测和化合物结构优化等技术服务，多方位满足用户的研发需求。
售后服务
相关视频
暂无
资料下载
暂无
联系方式
| 单位名称： |
|
详细地址：
静安区江场三路238号
|
|
qq：
2881954871
|
|
联系电话：
021-33632979
|
| Email： |
